The SLC16A7 gene helps cells move lactate and similar small fuel molecules across the cell membrane, especially in tissues with high energy needs such as the brain. If this gene does not work well, cells may have more trouble using and sharing energy, which can affect how well certain tissues function. Most variants in the SLC16A7 gene are not known to cause a clear inherited condition on their own, but researchers study it for its possible role in brain health and metabolism.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the instructions for producing proteins, the parts of cells that do the work. Others mainly guide when, where, and how strongly certain processes occur. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this topic more deeply, you can learn more in the LearnHub.
Overview
SLC16A7Gene function
What if the gene works
The SLC16A7 gene makes a transporter that moves lactate and ketones across cell membranes. This helps cells, especially nerve cells, use fuel efficiently.
Risk
What if the gene does not work
Milder to more severe variants in the SLC16A7 gene can reduce how well cells move lactate, pyruvate, and ketone bodies across the cell membrane. This can alter cellular energy use and signaling.
Treatment
What does that mean for your treatment
No SLC16A7-specific treatment or drug selection approach is currently established for people with a pathogenic or loss-of-function variant in the SLC16A7 gene. The SLC16A7 gene is being studied as a possible biomarker and drug target in some cancer and brain energy metabolism research.
Gene function
What if the gene works
Your cells need a steady way to move small fuel molecules across their outer membrane. The SLC16A7 gene provides instructions for a transporter that carries lactate, pyruvate, and related compounds from one side of the cell membrane to the other. This helps show how the SLC16A7 gene supports everyday energy use in many cells.
The SLC16A7 gene helps move lactate, pyruvate, and similar small fuel molecules across the cell membrane. Its protein works like a doorway, letting these compounds enter or leave cells as needed.
By transporting lactate and pyruvate, this gene helps cells access fuels that can be turned into energy. This is part of how the SLC16A7 gene helps cells use lactate for energy during normal daily activity.
The transporter usually moves these fuel molecules together with hydrogen ions, also called protons (tiny charged particles). This linked movement helps cells keep their internal acidity in a healthy range during normal metabolism.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help account for normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant can change a gene’s function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC16A7 gene can change the shape, stability, or cell surface placement of its transporter protein, which may reduce how well certain small energy related molecules cross the cell membrane. In understanding how SLC16A7 gene variants affect protein function, milder variants may only partly lower transport activity, while more disruptive variants can markedly impair folding, shorten protein survival, or stop the protein from reaching the membrane. This creates a spectrum from partial to near complete loss of activity.
How variants are linked to conditions
Current evidence has not yet established a broadly confirmed link between variants in the SLC16A7 gene and a specific health condition. Research on how SLC16A7 gene variants are linked to conditions is still developing, so anyone with a confirmed finding in this gene should rely on their own clinical report and genetics team for interpretation.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely present in the general population. Most do not have a direct effect on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC16A7 gene. If you have a change in SLC16A7 on genetic testing or concerns about family risk, a doctor or genetic counselor can help put it in context with your personal and family history.
Inheritance of SLC16A7 variants
There is not yet a broadly confirmed disease inheritance pattern for the SLC16A7 gene, so SLC16A7 gene variants inherited in families are not currently described with a well-established autosomal dominant, autosomal recessive, or X-linked pattern. As research develops, this picture may become clearer. The SLC16A7 gene is located on chromosome 12, which is an autosome, so you inherit one copy from each parent.
What does my SLC16A7 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for the SLC16A7 gene, although this can become clearer as research grows. If you have a specific SLC16A7 result and want to understand what it may mean for relatives, a doctor or genetic counselor can help explain it in the context of your family history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for SLC16A7 variants uses a blood or saliva sample to read the DNA sequence of the SLC16A7 gene and look for changes. Results may show a benign variant, a variant of uncertain significance, or a variant linked to disease, which helps clarify whether this gene change is medically relevant.
When should I consider getting a genetic test?
There is not yet a broadly established, SLC16A7-specific reason for genetic testing in routine care. Testing decisions are usually based on your symptoms, family history, and the possibility that a broader genetic test could be more helpful.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they explain varies by the condition and the specific type of variant. Many factors, including lifestyle, environment, age, and medical history, also influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered along with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work well for one person but less well for another. This is common and can influence both benefit and side effects, including how strongly someone feels a medicine’s effects.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how differences in genes affect the way people respond to medicines. It looks at gene and drug patterns to help explain why the same treatment can work differently from one person to another. With many medications, genes can influence how powerfully a drug works or how the body handles it. This information can support more informed, more individualized treatment choices. More detail on this topic is available in the LearnHub.
Drugs influenced by the SLC16A7 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, treatment changes, or how well a medicine is working are best discussed with your doctor.
History
The SLC16A7 gene entered the scientific literature in the late 1990s, when researchers were identifying members of the monocarboxylate transporter family and mapping where they were active in the body. Initially understood only through visible traits, later recognized as tied to a specific gene, this work helped separate SLC16A7 from closely related transport genes with similar names. Early studies focused on its activity in the brain and other tissues, which made it part of a broader effort to understand how cells handle energy related molecules. From these first observations, research expanded steadily, and SLC16A7 became better known in neuroscience and metabolism research. Its history is mainly a scientific one, shaped by careful laboratory work rather than public attention.